GlaxoSmithKline (NYSE:GSK)

investor research

Top Analyst Upgrades and Downgrades: Cisco, DreamWorks, Lululemon, Nabors, Schlumberger, Verizon and More

Stocks were indicated much lower on Tuesday as the market is dealing with lower commodities (oil and more) and a weak China and Europe. What has been proven repeatedly in ...
Read Full Story »
Volkswagen Golf 2015

Companies Spending the Most on R&D

For the third consecutive year, the company spending the most on research and development (R&D) was Germany’s Volkswagen. The automaker’s 2014 R&D spending will total $13.5 billion, just ahead of ...
Read Full Story »
Buffet

Significant Changes in Buffett and Berkshire Hathaway Holdings

Berkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2014. Warren Buffett’s portfolio has recently undergone some radical changes on the surface, some of ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Auxilium, BofA, Genworth, MGM, Walgreen, Wynn, Yahoo and More

Stocks were soft on Monday and investors still seem eager to find bargains or overlooked equity stories. 24/7 Wall St. reviews dozens of analyst reports each morning of the week ...
Read Full Story »
Buffet

Major Portfolio Changes for Warren Buffett and Berkshire Hathaway

Berkshire Hathaway Inc. (NYSE: BRK-A) released its public equity holdings as of June 30, 2014. Warren Buffett's different portfolio holdings have not been changing much of late, but it turns ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: AcelRx, Cisco, CIT, Juniper, Pfizer, Xerox and Many More

Stocks were down marginally in Monday's early indications, but it felt more like a day looking for direction. Still, investors are seeking upside from stocks. The difference now is that ...
Read Full Story »
Pentagon, defense

Pentagon Awards $409 Million in Defense Contracts

The Department of Defense awarded 10 defense contracts totaling $408.9 million in its Friday evening announcement of contract awards. Among the publicly traded companies winning contracts: Hewlett Packard (NYSE: HPQ) ...
Read Full Story »
biotech

Amgen Faces Cool Reception Over GSK Pact Termination

Amgen Inc. (NASDAQ: AMGN) submitted an SEC Filing showing that, as of April 1, its Amgen Manufacturing Ltd. subsidiary and GlaxoSmithKline PLC (NYSE: GSK), via Glaxo Group Ltd., have terminated ...
Read Full Story »
Warren Buffett

Meet the 2014 Warren Buffett and Berkshire Hathaway Stocks

As many consider Warren Buffett to be the greatest investor of modern times, investors want to know any time there are big changes in the Berkshire Hathaway Inc. (NYSE: BRK-A) ...
Read Full Story »
Warren Buffett

Buffett and Berkshire Hathaway Full Stock Holdings, Higher Again

Berkshire Hathaway Inc. (NYSE: BRK-A) and Warren Buffett have released the conglomerate's full stock holdings as of September 30, 2013. This 13F filing with the SEC shows that the company's ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Ariad, Hecla, HP, Micron and More

Earnings season has officially started, but the stock market and bond market are both dealing with the government shutdown, an upcoming debt ceiling and even the announcement of a new ...
Read Full Story »
Haiti

When Data Conflicts: Is the Malaria Vaccine Data Good or Bad?

A malaria vaccine is supposed to be a good thing. Right? Unfortunately that all depends. GlaxoSmithKline PLC (NYSE: GSK) currently plans to seek marketing approval for the first malaria vaccine ...
Read Full Story »
110898078

Will U.S. Default Risk Drive Money to Foreign Markets?

Investors have become increasingly anxious about how badly the U.S. equity and fixed income markets will be battered as the American government marches toward a potential default. Of course, investors ...
Read Full Story »
job_dissatisfaction_2

Big Pharma and 100,000 Jobs at Risk

Merck & Co. (NYSE: MRK) announced it would rid itself of 8,500 workers, many of whom work in the big pharmaceutical company's R&D operations. Since the return on research investment ...
Read Full Story »
biotech

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Investors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the population. From obesity to food allergies to prostate cancer, the ...
Read Full Story »